Letrodex Sciroxx

£37.00

Letrodex Sciroxx is a potent aromatase inhibitor containing letrozole for research into estrogen suppression pathways. Laboratory-grade formulation for in-vitro studies only.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Letrodex Sciroxx
Letrodex Sciroxx
£37.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview of Letrodex Sciroxx

Letrodex Sciroxx is a pharmaceutical-grade aromatase inhibitor formulation containing letrozole as the active compound. Letrozole belongs to the class of non-steroidal aromatase inhibitors that researchers investigate for its potent enzyme inhibition properties in laboratory settings. This compound demonstrates exceptional selectivity for the aromatase enzyme (CYP19A1), making it a valuable tool for studying estrogen biosynthesis pathways and hormonal modulation in controlled research environments. Scientists examining hormonal biochemistry utilise letrozole-based formulations to investigate the intricate mechanisms of estrogen production at the molecular level.

Laboratory Research Applications

Researchers at Stroid UK Shop examine letrozole for its effects on aromatase enzyme activity in cell culture models. Studies investigate how this compound modulates the conversion of androgens to estrogens through competitive enzyme inhibition. Laboratory investigations focus on letrozole’s role in estrogen-dependent cellular processes and its applications in endocrine research protocols. The compound’s high potency allows researchers to examine dose-dependent responses in various experimental models, providing insights into hormonal regulation mechanisms. Scientists studying metabolic pathways often incorporate letrozole research alongside investigations into selective receptor modulators and peptide signalling compounds. Research teams examining hormonal interactions frequently source their aromatase inhibitor compounds from established suppliers to ensure experimental consistency and data reliability across multi-centre collaborative studies.

Technical Specifications

Letrodex Sciroxx Research Compound Specifications
Property Value
Active Compound Letrozole
CAS Number 112809-51-5
Molecular Formula C₁₇H₁₁N₅
Molecular Weight 285.31 g/mol
Classification Non-steroidal aromatase inhibitor
Storage Requirements Room temperature, dry conditions

Research Compliance Statement

Letrodex Sciroxx is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, clinical use, or any diagnostic purposes. Research institutions must ensure proper handling protocols and maintain appropriate documentation for all experimental procedures involving this compound. This product is restricted to qualified researchers working in licensed laboratory facilities equipped for biochemical investigations.

Related